info@ibnsinapharma.com
+8802-41022150
SITEMAP
DSE
CSE
Home
About
Company Overview
Values
Mission & Vision
Quality Policy
History
Chairman's Message
Board of Directors
Awards & Accolades
Corporate Governance
Code of Conduct for the Board
Principle and Disclosure Policy
Dividend Distribution Policy
Nomination and Remuneration Policy
Milestone
Products
Pharma
General
By Brand Name
By Generic Name
By Therapeutic Class
Product List
PDF
Excel
Opthalmic
By Brand Name
By Generic Name
By Therapeutic Class
Product List
PDF
Excel
Natural
Herbal
By Brand Name
By Generic Name
By Therapeutic Class
Product List
PDF
Excel
Unani
By Brand Name
By Generic Name
By Therapeutic Class
Product List
PDF
Excel
Facilities
Pharma
Introduction
Production Facilities
Product Development
Quality Control
Quality Assurance
Natural
Introduction
Production Facilities
Product Development
Quality Control
Quality Assurance
API
Introduction
Production Facilities
Product Development
Quality Control
Quality Assurance
Investors
Price Sensitive Information
Quarterly Report
Annual Report
Financial Highlights
Corporate Brief
Share Holders' Information
Dividend Distribution Policy
Dividend History
Unclaimed Unsettled Dividend
Cash
Stock
Annual General Meeting (AGM)
News & Announcement
Share & Investors' Relation
Subsidiaries
The IBN SINA Natural Medicine Ltd
The IBN SINA API Industry Ltd
The IBN SINA Polymer Industry Ltd
Operations
Marketing
Global Operation
Sales and Distribution
Unclaimed Unsettled Dividend
Investors
Unclaimed-unsettled-dividend
2022-23
2022-23
2018-19
UNCLAIMED UNSETTLED DIVIDEND 2019
2017-18
UNCLAIMED UNSETTLED DIVIDEND 2018
2016-17
UNCLAIMED UNSETTLED DIVIDEND 2017
2015-16
UNCLAIMED UNSETTLED DIVIDEND 2016
2014-15
UNCLAIMED UNSETTLED DIVIDEND 2015
Price Sensitive Information
Quarterly Report
Annual Report
Financial Highlights
Corporate Brief
Share Holders' Information
Dividend Distribution Policy
Dividend History
Unclaimed Unsettled Dividend
Annual General Meeting (AGM)
News & Announcement
Share & Investors' Relation
